Clinical trial No longer in our active list Observational Ages 18 and up

Using artificial intelligence to predict abdominal aortic aneurysm shrinkage after stent placement

Official title: Prediction of Abdominal Aortic Aneurysm Shrinkage After Endovascular Repair With Artificial Intelligence

Run by Rijnstate Hospital · NCT06250998 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether artificial intelligence can help predict how much an abdominal aortic aneurysm will shrink after patients have a stent placed.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorRijnstate Hospital
Academic / other
Locations5 sites (Arnhem, Non US/Canada and 4 other locations)
Trial IDNCT06250998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have undergone technically successful elective EVAR for unruptured infrarenal AAA.

Probably not a fit

Patients with ruptured or symptomatic AAA, or those treated with specific types of endografts not included in the study, will not benefit from this research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify factors that contribute to successful treatment outcomes in patients who have undergone elective endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). The primary objective is to develop a predictive model for the shrinkage of AAA one year post-treatment using artificial intelligence. Eligible patients must have received specific types of endografts and have follow-up imaging available for analysis. The study will analyze preoperative imaging data to enhance understanding of aneurysm remodeling.

Why it matters

Potential benefit: If successful, this study could lead to improved predictions of aneurysm shrinkage, allowing for better patient management and outcomes.

How similar studies have gone: While the use of artificial intelligence in predicting treatment outcomes is a growing field, this specific approach to AAA shrinkage prediction is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years;
* Elective, initially technically successful (as described by the ESVS guidelines11), infrarenal EVAR for unruptured infrarenal AAA;
* Implanted endograft is a Gore Excluder, Medtronic Endurant, Cook Zenith, Cordis Incraft, Endologix AFX, Jotec E-Tegra, or Vascutek Anaconda endograft;
* Follow-up of the AAA of at least one year with imaging of the same modality as the preoperative imaging;
* Axial reconstructions of preoperative CT angiography available, preferably in the arterial phase and with 3 mm or smaller slice thickness.

Exclusion Criteria:

* Patients with ruptured or symptomatic AAA;
* Patients that were treated with fenestrated or branched endografts, iliac branched devices, non-CE marked devices within trial setting, other endografts (EVAS cases) or chimney procedures;
* Acute procedures;
* Reintervention before one year follow-up;
* Revision cases after previous open or endovascular aneurysm repair of an AAA;

Where it's running

  • Rijnstate Hospital
    Arnhem, Non US/Canada, Netherlands
    Recruiting
  • Amsterdam UMC
    Amsterdam, Netherlands
    Recruiting
  • Medisch Spectrum Twente
    Enschede, Netherlands
    Recruiting
  • Universitair Medisch Centrum Groningen
    Groningen, Netherlands
    Recruiting
  • Karolinksa Institutet
    Stockholm, Sweden
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.